Skip to content

Study of the clinical efficacy of Tongdutiaoshen acupuncture on sleep disorder patients with maintenance hemodialysis caused by the end-stagerenal disease

Study of the clinical efficacy of Tongdutiaoshen acupuncture on sleep disorder patients with maintenance hemodialysis caused by the end-stagerenal disease

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006364
Enrollment
Unknown
Registered
2022-07-13
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep disorder patients with maintenance hemodialysis caused by the end-stagerenal disease

Interventions

Test team:Estazolam and "Tongdutiaoshen" acupuncture treatment

Sponsors

Beijing Luhe Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.18-80 years old; 2. Met the diagnostic criteria for maintenance hemodialysis; 3.Met the diagnostic criteria for sleep disorders; 4. Did not use sleep-affecting drugs, such as aminobutyrate A complex agonists, anxiolytic, antidepressants, etc, or stop the medication for more than 2 weeks; 5. Assessed sleep quality using a PSQI score, total points > 7; 6. Willing to cooperate and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. With severe acute cardiovascular and cerebrovascular diseases; 2. With neurological and psychiatric diseases, unable partners; 3. With sleep disorders caused by other factors (such as environmental, physiological, drugs, pain, infection, and systemic diseases); 4.Moderate and severe depression patients (SDS standard score of Depression Self-assessment Scale?63); 5. Progressive malignant tumors or other serious wasting diseases, easy to be infected with patients; 6.With severe coagulation dysfunction; 7.There are serious infected person, needle fear; 8. With severe allergies to metals.

Design outcomes

Primary

MeasureTime frame
PSQI;Traditional Chinese medicine waiting points of insomnia;Therapeutic evaluation;

Secondary

MeasureTime frame
Sleep monitoring;Laboratory indicators;

Countries

China

Contacts

Public ContactLi Min
lhyylimin@mail.ccmu.edu.cn010-69543901-6320

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026